ASCO GU 2019: Updates on non-metastatic castration-resistant prostate cancer (CRPC) from focused group discussion topics Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 10 min 80 sec ✓ Published: 16-Feb-2019
Description: Professor Karim Fizazi chairs a discussion with Professors Eleni Efstathiou, Nicholas Mottet, and Boris Hadaschek on the latest data presented at ASCO GU 2019 in San Francisco, specifically focused on patients with non-metastatic CRPC.nnThe group highlights the clinical landscape and treatment recommendations for these patients, and discuss how new data presented at ASCO GU, such the ARAMIS and SPARTAN studies, may impact treatment regimens and guidelines for this patient population.nnTopics inc
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)